SRD5A2 and prostate carcinoma: These enzymes(expressed in the nucleus and cytoplasm of, for example, prostate epithelial cells) (10) are encoded by the 5α-reductasetype 2 (SRD5A2) gene, and polymorphisms of this gene (leading to increased5α-reductase activity and DHT concentrations in prostate) have beenhypothesized to increase risk of prostate cancer (11).